Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma. [electronic resource]
Producer: 20110215Description: 5470-8 p. digitalISSN:- 0008-543X
- Adolescent
- Adult
- Bone Neoplasms -- radiotherapy
- Female
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Male
- Organometallic Compounds -- adverse effects
- Organophosphorus Compounds -- adverse effects
- Osteosarcoma -- radiotherapy
- Radiometry
- Radiopharmaceuticals -- adverse effects
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.